Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) No 677/2014 of 19 June 2014 amending Regulation (EU) No 37/2010, as regards the substance ‘cabergoline’ Text with EEA relevance
Commission Implementing Regulation (EU) No 677/2014 of 19 June 2014 amending Regulation (EU) No 37/2010, as regards the substance ‘cabergoline’ Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 18 August 2014.
Supplementary provisions
ANNEXSupplementary provisions
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Cabergoline Cabergoline Bovine 0,10 μg/kg Fat NO ENTRY Prolactin inhibitor’ 0,25 μg/kg Liver 0,50 μg/kg Kidney 0,15 μg/kg Muscle 0,10 μg/kg Milk
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview